ANDRINI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 111
NA - Nord America 83
AS - Asia 54
SA - Sud America 5
AF - Africa 3
Totale 256
Nazione #
US - Stati Uniti d'America 81
IT - Italia 40
CN - Cina 27
FR - Francia 24
DE - Germania 11
IE - Irlanda 8
GB - Regno Unito 7
BG - Bulgaria 6
AE - Emirati Arabi Uniti 5
HK - Hong Kong 5
IN - India 4
JP - Giappone 4
PE - Perù 4
NL - Olanda 3
ES - Italia 2
KR - Corea 2
MA - Marocco 2
PL - Polonia 2
RU - Federazione Russa 2
SG - Singapore 2
TW - Taiwan 2
UA - Ucraina 2
AT - Austria 1
BR - Brasile 1
CA - Canada 1
EG - Egitto 1
FI - Finlandia 1
GR - Grecia 1
IR - Iran 1
MX - Messico 1
PK - Pakistan 1
RO - Romania 1
TR - Turchia 1
Totale 256
Città #
Ashburn 19
Bologna 15
Dublin 9
Santa Cruz 6
Sofia 6
Philadelphia 5
Lima 4
Amsterdam 3
Newcastle upon Tyne 3
Paris 3
Shanghai 3
Southend 3
Boardman 2
Buffalo 2
Bydgoszcz 2
Cedar Knolls 2
Cesena 2
Chicago 2
Dallas 2
Forlì 2
Genoa 2
Hayamiya 2
Milan 2
Morgantown 2
Nador 2
San Pietro Vernotico 2
Shenzhen 2
Taipei 2
Tianjin 2
Vimercate 2
Westerly 2
Yeongdeungpo-gu 2
Zhengzhou 2
Ankara 1
Atlanta 1
Beijing 1
Bucharest 1
Coyoacán 1
Córdoba 1
Denver 1
Durham 1
Fairfield 1
Florence 1
Grenoble 1
Guangzhou 1
Gunzenhausen 1
Heimsheim 1
Helsinki 1
Heraklion 1
Hong Kong 1
Hyderabad 1
Los Angeles 1
Memphis 1
Milpitas 1
Monmouth Junction 1
Montréal 1
Mount Olive 1
Mountain View 1
New York 1
Norfolk 1
Olalla 1
Padova 1
Pune 1
Reggio Nell'emilia 1
Roccadaspide 1
Rockville 1
Rome 1
Saint Petersburg 1
Seattle 1
Singapore 1
Stanford 1
Sukkur 1
São Paulo 1
Torino 1
Udine 1
Waidhofen an der Ybbs 1
Weehawken 1
Totale 165
Nome #
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players?, file e1dcb336-1a59-7715-e053-1705fe0a6cc9 74
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis, file daaf9a96-62fe-4804-8a7c-cbc186258b74 55
Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review, file 9010cdaf-e682-43e3-87b2-cd733cfab00d 27
Multimodal strategy in localized merkel cell carcinoma: Where are we and where are we heading?, file e1dcb338-fdca-7715-e053-1705fe0a6cc9 19
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution, file f87a8da1-e348-4068-9e25-b66c438d2023 18
Bone targeting agents in patients with metastatic prostate cancer: State of the art, file 2ade106e-ebd8-4681-a542-f5f344f0bbad 14
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges, file e1dcb33a-1041-7715-e053-1705fe0a6cc9 14
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors, file 92128a49-f7d5-43c1-b42f-be922ec1546f 13
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis, file d20288e1-8547-4bf6-b84c-759e1877e038 9
An Update on Appendiceal Neuroendocrine Tumors, file d083dc62-1586-44b2-b756-758ca9297ef6 4
Peripheral nervous system adverse events associated with immune checkpoint inhibitors, file 77ec4bf0-41ef-4b01-a932-4634ebeca082 3
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis, file 7f015f95-5ef4-4f8b-a6aa-d3a17b9be323 3
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET), file a23e3aca-769d-4254-8c6e-136beaa9bd48 3
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations, file 222b91e3-bd01-4fe2-a46f-6955d14762ca 2
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations, file 7ae06153-19d3-4683-b009-351ec0180613 1
Totale 259
Categoria #
all - tutte 1.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 1 1 4 3 0 7
2021/202235 2 1 3 1 3 0 2 0 2 3 12 6
2022/202364 1 0 4 7 3 1 3 4 9 8 14 10
2023/2024144 2 8 8 10 9 37 11 13 30 16 0 0
Totale 259